AAROGYAM 1.3 WITH UTSH IN

AAROGYAM 1.3 WITH UTSH

₹3100~~₹5999~~

48% OFF on MRP

₹3100₹5999

100 Test(s)

Home Visit

On This Product

buy 1+1, Get extra ₹250 OFF

buy 1+2, Get extra ₹500 OFF

Product NameAAROGYAM 1.3 WITH UTSH
Smart ReportNo
Doctor ConsultationNo
Center VisitNo
Total Tests Covered 100-Test(s)
Disease /Body PartFever, Vitamin, Elements, Blood, Heart, Fertility, Covid, Kidney, Hair_skin, Lungs, Pregnancy, Thyroid, Cancer, Bone, Diabetic, Liver
Sample TypeBlood
FastingFasting Required

Lab NameThyrocare Technologies Ltd
About Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai, the company has a total of 2K plus outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. They have fully automated diagnostic laboratory set up covering over 2,00,000 sq. ft. floor space that ensures error-free processing of over 1,00,000 specimens and over 4,00,000 Clinical Chemistry investigations per night.

Stringent Quality Measures

20 + Years of experience

25 NABL Accredited Laboratories

2K+ Outlets & Collection Centers

400000 Samples Processed Per Day

	Quality Glossary Definition: ISO 9001. ISO 9001 is defined as the international standard that specifies requirements for a quality management system (QMS)
	The CAP accredits laboratories performing testing on specimens from human beings or animals, using methodologies and clinical application within the expertise of the program
	The National Accreditation Board for Testing and Calibration Laboratories (NABL) is an autonomous body under the guidance of the Dept. Of Science & Technology, Govt. of India whose purpose is to provide accreditation to testing and calibration of clinical laboratories in the country.
	The purpose of the NGSP is to standardize Hemoglobin A1c test results to those of the Diabetes Control and Complications Trial (DCCT) and United Kingdom Prospective Diabetes Study (UKPDS) which established the direct relationships between HbA1c levels and outcome risks in patients with diabetes.